World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 30949534

Number of visits today: 6716

Number of downloads: 13478724

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Montenegro MF, González-Guerrero R, Sánchez-Del-Campo L, Piñero-Madrona A, Cabezas-Herrera J, Rodríguez-López JN. PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation. Sci Rep 2020;10:13275. [PMID: 32764667 DOI: 10.1038/s41598-020-70289-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]

For:

Montenegro MF, González-Guerrero R, Sánchez-Del-Campo L, Piñero-Madrona A, Cabezas-Herrera J, Rodríguez-López JN. PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation. Sci Rep 2020;10:13275. [PMID: 32764667 DOI: 10.1038/s41598-020-70289-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]

Number	Citing Articles
1	Li Z, Wang D, Chen X, Wang W, Wang P, Hou P, Li M, Chu S, Qiao S, Zheng J, Bai J. PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis. Cell Death Dis 2021;12:1080. [PMID: 34775498 DOI: 10.1038/s41419-021-04381-5] [Reference Citation Analysis]
2	Carlos-Reyes A, Muñiz-Lino MA, Romero-Garcia S, López-Camarillo C, Hernández-de la Cruz ON. Biological Adaptations of Tumor Cells to Radiation Therapy. Front Oncol 2021;11:718636. [PMID: 34900673 DOI: 10.3389/fonc.2021.718636] [Reference Citation Analysis]
3	Wu Y, Liu H, Gong Y, Zhang B, Chen W. ANKRD22 enhances breast cancer cell malignancy by activating the Wnt/β-catenin pathway via modulating NuSAP1 expression. Bosn J Basic Med Sci 2021;21:294-304. [PMID: 32651974 DOI: 10.17305/bjbms.2020.4701] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4	Hsu WJ, Chen CH, Chang YC, Cheng CH, TsaI YH, Lin CW. PRMT1 Confers Resistance to Olaparib via Modulating MYC Signaling in Triple-Negative Breast Cancer. J Pers Med 2021;11:1009. [PMID: 34683150 DOI: 10.3390/jpm11101009] [Reference Citation Analysis]
5	Cheng C, Pei X, Li SW, Yang J, Li C, Tang J, Hu K, Huang G, Min WP, Sang Y. CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing β-catenin. Oncogene 2021;40:2842-57. [PMID: 33742119 DOI: 10.1038/s41388-021-01692-x] [Reference Citation Analysis]
6	Repenning A, Happel D, Bouchard C, Meixner M, Verel-Yilmaz Y, Raifer H, Holembowski L, Krause E, Kremmer E, Feederle R, Keber CU, Lohoff M, Slater EP, Bartsch DK, Bauer UM. PRMT1 promotes the tumor suppressor function of p14^ARF and is indicative for pancreatic cancer prognosis. EMBO J 2021;40:e106777. [PMID: 33999432 DOI: 10.15252/embj.2020106777] [Cited by in F6Publishing: 1] [Reference Citation Analysis]